Home600276 • SHA
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Previous close
¥43.70
Day range
¥43.50 - ¥44.97
Year range
¥35.51 - ¥50.50
Market cap
278.76B CNY
Avg Volume
29.08M
P/E ratio
63.63
Dividend yield
0.36%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 6.00B | 9.20% |
Operating expense | 3.58B | 5.60% |
Net income | 1.37B | 10.48% |
Net profit margin | 22.82 | 1.15% |
Earnings per share | 0.23 | — |
EBITDA | 1.64B | 18.91% |
Effective tax rate | 8.99% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.77B | 36.27% |
Total assets | 46.34B | 9.57% |
Total liabilities | 3.90B | 38.33% |
Total equity | 42.44B | — |
Shares outstanding | 6.52B | — |
Price to book | 6.81 | — |
Return on assets | 8.20% | — |
Return on capital | 8.83% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 1.37B | 10.48% |
Cash from operations | 1.25B | 486.35% |
Cash from investing | -750.39M | -213.71% |
Cash from financing | -18.13M | 98.76% |
Net change in cash | 467.87M | 177.85% |
Free cash flow | 9.75M | 100.91% |
About
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Founded
Apr 28, 1997
Website
Employees
19,611